Minerva Imaging is a scientifically driven CRO and CDMO specialized in targeted radionuclide therapies. The company focusses on the use of advanced models within oncology, cardiovascular diseases and in vivo molecular imaging for translational research and drug development. Minerva Imaging engages with its clients to understand their scientific questions and discuss how its methods and capabilities can provide answers. The facility located in Denmark offers best–in–industry fully integrated radiopharmaceutical research, drug development and manufacturing services.
Company Details
- Employees
- 174
- Founded
- -
- Address
- Lyshøjvej 21, Ølstykke,capital Region 3650,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- minervaimaging.com
- Keywords
- Research, Drug development, Molecular Imaging, Animal models, CRO, Cancer, Inflammation, Cardiovascular disease, Oncology, CDMO, Radiopharmaceuticals.
- HQ
- Ølstykke, Capital Region
Minerva Imaging Questions
Minerva Imaging's website is minervaimaging.com
Minerva Imaging's LinkedIn profile is https://dk.linkedin.com/company/minerva-imaging
Minerva Imaging has
174 employees.
View email and phone details for 174
employees at Minerva Imaging.
Minerva Imaging's industry is
Biotechnology Research
Minerva Imaging's top competitors are
Lundbeck,
Nordic Bioscience,
Novo Nordisk,
Bavarian Nordic,
Gubra,
Evaxion A/s,
Genmab,
Zealand Pharma,
Novonesis,
Agc Biologics.
Minerva Imaging's categories are Biotechnology Research
Minerva Imaging's founding year is 2011
